“Prognostic Value of Neutrophil-to-Lymphocyte Ratio in MCRPC Patients Treated With Abiraterone, Enzalutamide and Docetaxel: A Retrospective Single-Center Study”. 2026. Archivio Italiano Di Urologia E Andrologia, August. https://doi.org/10.4081/aiua.2026.15630.